Boston Scientific Announces Agreement To Acquire NxThera

Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia MARLBOROUGH, Mass., March 21, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) today announced that it ... Devices, Urology, Mergers & Acquisitions Boston Scientific, NxThera, Rezūm, benign prostatic hyperplasia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news